
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc.(EFTR)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · EFTR · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
2
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
eFFECTOR Therapeutics, Inc.内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
EFTR 季度内部人买卖趋势
EFTR 内幕交易卖出 · EFTR 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
EFTR 高管卖出股份 · EFTR 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 15, 2024 | Byrnes Michael CFO | Award | 1,387 | $2K | Form 4 |
| May 15, 2024 | WORLAND STEPHEN T CEO · Director | Award | 1,806 | $3K | Form 4 |
| Nov 27, 2023 | SR ONE CAPITAL MANAGEMENT, LLC 10 percent owner | Sale | 430,578 | $261K | Form 4 |
| Nov 27, 2023 | SR ONE CAPITAL MANAGEMENT, LLC 10 percent owner | Sale | 178,585 | $108K | Form 4 |
| Nov 15, 2023 | WORLAND STEPHEN T CEO · Director | Award | 5,979 | $3K | Form 4 |
| Nov 15, 2023 | Byrnes Michael CFO | Award | 4,524 | $2K | Form 4 |
| Aug 11, 2023 | WORLAND STEPHEN T CEO · Director | Option | 33,799 | $18K | Form 4 |
| May 15, 2023 | WORLAND STEPHEN T CEO · Director | Award | 6,401 | $3K | Form 4 |
| May 15, 2023 | Byrnes Michael CFO | Award | 4,863 | $2K | Form 4 |
| Nov 15, 2022 | Byrnes Michael CFO | Award | 4,651 | $2K | Form 4 |
| Nov 15, 2022 | WORLAND STEPHEN T CEO | Award | 6,047 | $3K | Form 4 |
| Oct 4, 2022 | Ehrlich Christopher B Director | Purchase | 346 | $197 | Form 4 |
| Sep 26, 2022 | Ehrlich Christopher B Director | Purchase | 18,867 | $10K | Form 4 |
| Aug 1, 2022 | Presidio Management Group X LLC 10 percent owner | Sale | 25,896 | $20K | Form 4 |
| Aug 2, 2022 | Presidio Management Group X LLC 10 percent owner | Sale | 27,348 | $22K | Form 4 |
| Aug 3, 2022 | Presidio Management Group X LLC 10 percent owner | Sale | 57,580 | $46K | Form 4 |
| Aug 1, 2022 | Presidio Management Group X LLC 10 percent owner | Sale | 807 | $634 | Form 4 |
| Aug 2, 2022 | Presidio Management Group X LLC 10 percent owner | Sale | 853 | $680 | Form 4 |
| Aug 1, 2022 | ROOT JONATHAN D Director | Sale | 1,796 | $1K | Form 4 |
| Aug 3, 2022 | Presidio Management Group X LLC 10 percent owner | Sale | 1,796 | $1K | Form 4 |
| Jul 28, 2022 | Presidio Management Group X LLC 10 percent owner | Sale | 31,533 | $28K | Form 4 |
| Jul 28, 2022 | Presidio Management Group X LLC 10 percent owner | Sale | 984 | $878 | Form 4 |
| Jul 28, 2022 | ROOT JONATHAN D Director | Sale | 984 | $878 | Form 4 |
| Jul 25, 2022 | Presidio Management Group X LLC 10 percent owner | Sale | 2,210 | $2K | Form 4 |
| Jul 26, 2022 | Presidio Management Group X LLC 10 percent owner | Sale | 2,691 | $2K | Form 4 |
SR ONE CAPITAL MANAGEMENT, LLC
10 percent owner
日期
Nov 27
股数
430,578
均价
$0.61
总金额
$261K
SR ONE CAPITAL MANAGEMENT, LLC
10 percent owner
日期
Nov 27
股数
178,585
均价
$0.61
总金额
$108K
Presidio Management Group X LLC
10 percent owner
日期
Aug 1
股数
25,896
均价
$0.79
总金额
$20K
Presidio Management Group X LLC
10 percent owner
日期
Aug 2
股数
27,348
均价
$0.80
总金额
$22K
Presidio Management Group X LLC
10 percent owner
日期
Aug 3
股数
57,580
均价
$0.80
总金额
$46K
Presidio Management Group X LLC
10 percent owner
日期
Aug 3
股数
1,796
均价
$0.80
总金额
$1K
Presidio Management Group X LLC
10 percent owner
日期
Jul 28
股数
31,533
均价
$0.89
总金额
$28K
Presidio Management Group X LLC
10 percent owner
日期
Jul 28
股数
984
均价
$0.89
总金额
$878
Presidio Management Group X LLC
10 percent owner
日期
Jul 25
股数
2,210
均价
$0.93
总金额
$2K
Presidio Management Group X LLC
10 percent owner
日期
Jul 26
股数
2,691
均价
$0.90
总金额
$2K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 EFTR 内幕交易
EFTR 内幕交易
eFFECTOR Therapeutics, Inc.(EFTR)内幕交易数据来源于公司内部人(包括EFTR)提交的SEC Form 4申报文件。过去12个月内,0位内部人向SEC提交了交易申报。EFTR内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看eFFECTOR Therapeutics, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
EFTR 内幕交易 · 5个问题eFFECTOR Therapeutics, Inc.(EFTR)的内部人包括高管和董事,如EFTR等。过去12个月内,0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026